India restricts the export of medicines worldwide – COVID-19

In response to the epidemic of the coronavirus, the government of India on Tuesday has restricted the export of 26 drugs and their components, including broad-spectrum antibiotics and some vitamins, which means that new coronavirus may soon have an impact on people around the world with other diseases.

The world largely depends on the huge pharmaceutical industry in India in production of generic drugs, but Indian officials are concerned about the supply for their own country.

Indian drug manufacturers depend on Chinese factories for key ingredients of drugs, especially in relation to the antibiotics and vitamins. Flash Covid-19 in China and quarantine of Hubei province, where much of the production has seriously undermined China’s ability to produce these ingredients.

Although Indian companies have accumulated additional ingredients in anticipation of the annual New year according to the lunar calendar, these reserves are now depleted.

It is unclear whether completely stopped the export of these drugs to India. The government decree States that export of drugs is limited, which means to send out of the country requires government approval.

Antibiotics, which are subject to restrictions, is tinidazole, metronidazole, chloramphenicol, erythromycin salts, neomycin salt of clindamycin, and Ornidazole.

Other drugs of the short-list include the painkiller acetaminophen, hormone progesterone, the antiviral drug acyclovir, and vitamins B1, B6 and B12.